Skip to main content
logo
Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.730
+0.320 (22.70%)
At close: Sep 26, 2025, 4:00 PM EDT
1.790
+0.060 (3.47%)
After-hours: Sep 26, 2025, 7:59 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Novel Therapeutics
391.70K
Log In
Log In
Log In
Novel Therapeutics Growth
-73.93%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
391.70K
Log In
Log In
Log In
United States Growth
-73.93%
Log In
Log In
Log In